Search research articles
Contact Us
Filters
Showing results (1-10 of 50) with videos related to
Page
of 5
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
August 16, 2021
New-onset status epilepticus in SARS-CoV-2 infection: a case series
Marco Belluzzo, Annacarmen Nilo, Mariarosaria Valente, et al.
Expert Opinion on Investigational Drugs
|
July 21, 2017
Investigational therapies for the treatment of narcolepsy
Stefano de Biase, Annacarmen Nilo, Gian Luigi Gigli, et al.
Biomedicines
|
January 21, 2023
Seizures, Epilepsy, and NORSE Secondary to Autoimmune Encephalitis: A Practical Guide for Clinicians
Alberto Vogrig, Gian Luigi Gigli, Annacarmen Nilo, et al.
Neurophysiologie Clinique = Clinical Neurophysiology
|
February 29, 2024
Epilepsy with eyelid myoclonia (Jeavons syndrome): Generalized, focal, or combined generalized and focal epilepsy syndrome?
Philippe Gélisse, Carlos Gallegos, Annacarmen Nilo, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
December 23, 2018
Pharmacokinetic and pharmacodynamic considerations for the clinical efficacy of perampanel in focal onset seizures
Stefano de Biase, Gian Luigi Gigli, Annacarmen Nilo, et al.
Sleep Medicine
|
March 24, 2022
Turning off the siren of the night: botulinum toxin for the treatment of nocturnal groaning. A case series
Yan Tereshko, Christian Lettieri, Gian Luigi Gigli, et al.
Seizure
|
March 7, 2021
Epilepsy with eyelid myoclonias (Jeavons syndrome): An electro-clinical study of 40 patients from childhood to adulthood
Annacarmen Nilo, Arielle Crespel, Pierre Genton, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
March 14, 2024
A comprehensive update on the ADMET considerations for α2δ calcium channel ligand medications for treating restless legs syndrome
Gaia Pellitteri, Salvatore Versace, Giovanni Merlino, et al.
Epilepsy & Behavior Reports
|
January 18, 2021
Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up
Annacarmen Nilo, Giada Pauletto, Gian Luigi Gigli, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 23, 2024
Efficacy of Perampanel in Refractory and Super-Refractory Status Epilepticus with Suspected Inflammatory Etiology: A Case Series
Annacarmen Nilo, Alberto Vogrig, Marco Belluzzo, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 50) with videos related to
Sort By:
Page
of 5
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
August 16, 2021
New-onset status epilepticus in SARS-CoV-2 infection: a case series
Marco Belluzzo, Annacarmen Nilo, Mariarosaria Valente, et al.
Expert Opinion on Investigational Drugs
|
July 21, 2017
Investigational therapies for the treatment of narcolepsy
Stefano de Biase, Annacarmen Nilo, Gian Luigi Gigli, et al.
Biomedicines
|
January 21, 2023
Seizures, Epilepsy, and NORSE Secondary to Autoimmune Encephalitis: A Practical Guide for Clinicians
Alberto Vogrig, Gian Luigi Gigli, Annacarmen Nilo, et al.
Neurophysiologie Clinique = Clinical Neurophysiology
|
February 29, 2024
Epilepsy with eyelid myoclonia (Jeavons syndrome): Generalized, focal, or combined generalized and focal epilepsy syndrome?
Philippe Gélisse, Carlos Gallegos, Annacarmen Nilo, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
December 23, 2018
Pharmacokinetic and pharmacodynamic considerations for the clinical efficacy of perampanel in focal onset seizures
Stefano de Biase, Gian Luigi Gigli, Annacarmen Nilo, et al.
Sleep Medicine
|
March 24, 2022
Turning off the siren of the night: botulinum toxin for the treatment of nocturnal groaning. A case series
Yan Tereshko, Christian Lettieri, Gian Luigi Gigli, et al.
Seizure
|
March 7, 2021
Epilepsy with eyelid myoclonias (Jeavons syndrome): An electro-clinical study of 40 patients from childhood to adulthood
Annacarmen Nilo, Arielle Crespel, Pierre Genton, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
March 14, 2024
A comprehensive update on the ADMET considerations for α2δ calcium channel ligand medications for treating restless legs syndrome
Gaia Pellitteri, Salvatore Versace, Giovanni Merlino, et al.
Epilepsy & Behavior Reports
|
January 18, 2021
Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up
Annacarmen Nilo, Giada Pauletto, Gian Luigi Gigli, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 23, 2024
Efficacy of Perampanel in Refractory and Super-Refractory Status Epilepticus with Suspected Inflammatory Etiology: A Case Series
Annacarmen Nilo, Alberto Vogrig, Marco Belluzzo, et al.
Page
of 5